adimab.com
Get leads like Adimab — and thousands more
Build targeted lists by tech stack, traffic, and more
Adimab: The Quiet Giant of Antibody Discovery
How a 200-person team commands $39M in revenue with a proprietary yeast platform.
In the high-stakes world of biotech, Adimab operates like a stealth fighter: invisible to the public eye but lethal in its precision. While giants like Genentech spend billions on discovery, this Lebanon, NH-based firm leverages a proprietary yeast display platform to engineer antibodies with clinical success rates that defy industry averages.
"Adimab doesn't just discover antibodies—they engineer developability, turning yeast into the most valuable asset in biopharma."
The Platform Advantage
Unlike traditional hybridoma methods, Adimab's yeast display platform allows for rapid, high-throughput screening of billions of antibody variants. This isn't just faster; it's smarter. By focusing on developability from day one, they eliminate the 'fail late' syndrome that plagues the industry. Their co-founders—Tillman Gerngross and Dane Wittrup—built a system that prioritizes clinical success over sheer volume.
Traffic Tells the Story
With only 3,820 monthly visits and a global rank of #3,760,867, Adimab isn't chasing clicks. They're chasing cures. The data reveals a B2B powerhouse: 48% direct traffic suggests a captive audience of partners and researchers, while 28% organic search points to niche, high-intent queries like 'multispecific antibody therapeutic.' They don't need mass appeal; they need the right eyes.
The keyword data is telling. 'Adimab' itself commands 690 monthly searches, but it's the long-tail terms—like 'laura walker papers adimab' (120 searches)—that reveal their academic and industry gravity. This isn't a consumer brand; it's a scientific institution. Their tech stack (jQuery, Tailwind, Bootstrap) is utilitarian, not flashy, reflecting a focus on function over form.
- Proprietary yeast display platform for high-throughput antibody screening
- Focus on developability to reduce clinical failure rates
- Strategic partnerships with major pharma (undisclosed in public data)
- Lean team of 203 generating $39M in revenue ($193K/employee)
The Unsung Engine of Modern Biotech
Adimab proves that in healthcare, impact isn't measured in pageviews—it's measured in pipelines.
What tech stack does Adimab use?
How much traffic does Adimab get?
Traffic & Engagement
Traffic Sources
Where is Adimab's audience located?
What keywords does Adimab rank for?
5 keywordsHow is Adimab's SEO?
Meta Tags
Antibody Discovery And Engineering Platform | Adimab
Accelerate antibody therapeutics with Adimab’s yeast-based antibody discovery and engineering platform built for developability and clinical success.
H1 Tags
Schema Types
What is Adimab's revenue?
Who works at Adimab?
Loading leads...
What do customers think of Adimab?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Adimab
What is Adimab's Revenue?
What does Adimab do?
How fast is Adimab growing?
What technologies does Adimab use?
Who are Adimab's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Adimab?
Social Profiles
Contact Information
Export adimab.com Data
Download the complete tech stack, analytics, leads, and company data for adimab.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About adimab.com
Accelerate antibody therapeutics with Adimab’s yeast-based antibody discovery and engineering platform built for developability and clinical success.
Company Overview
adimab.com Social Media
Contact adimab.com
Phone Numbers
Technology Stack
adimab.com uses 18 technologies across their website including Google Fonts, HSTS, PHP, and more.
Fonts
Google Fonts
Security
HSTS
Programming Languages
PHP
CMS
WordPress
CDN
jsDelivr
Privacy & Consent
CookieYes
Traffic & Audience
adimab.com receives approximately 3.8K monthly visitors and ranks #3,760,867 globally. The website has a bounce rate of 36% with visitors viewing an average of 2.9 pages per visit. Users spend an average of 0:41 on the site.
The majority of adimab.com's traffic comes from .
Frequently Asked Questions
What is adimab.com?
What technologies does adimab.com use?
How do I contact adimab.com?
What are adimab.com's social media accounts?
Is adimab.com hiring?
How popular is adimab.com?
Related Searches
This page provides publicly available information about adimab.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit adimab.com directly at https://adimab.com.